MK-1084, Merck’s investigational KRAS G12C inhibitor, showed a manageable safety profile along with antitumor activity in the ...

Immatics’ cell therapy has been linked to a 56% objective response rate (ORR) among 32 heavily pretreated patients with ...

SaveHealth provides an in-depth look at cholesterol-fighting atorvastatin, its mechanism of action, clinical significance, ...

Phase III progression-free survival data were positive for first-line Braftovi in first-line combination therapy for mCRC.

The FDA biologics license application for patritumab deruxtecan in EGFR+ NSCLC has been withdrawn following discussions with ...

Pfizer Inc. (NYSE: PFE) today announced statistically significant and clinically meaningful survival results from the Phase 3 ...

ASCO annual meeting featured a prostate cancer trials in progress session and a presentation by Dr. Scott T. Tagawa discussing ProstACT Global, a phase 3 study of 177 Lu-rosptamab + standard of care ...

If you're considering renting a car in Alaska, be sure to read these tips first! You'll find out everything you wanted to ...

The calcitic layers of the eggshells of archosaurs (including crocodilians and birds) and turtles are composed of distinctive ...

According to SMM statistics, overseas metallurgical-grade alumina production in April 2025 increased by 3.8% YoY, with the average operating rate of overseas alumina refineries reaching 82.2%, up 0.3% ...

"These results give us confidence that this regimen could become the new standard of care in the first-line setting, having demonstrated a substantial benefit on patient outcomes and quality of life." ...